EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Respiratory Syncytial Virus and COVID‐19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use

Jose-Reynaldo Homen Fernandez iD, Inés Armenteros, Adrián Valls Carbó iD, Julia Barrado, Carolina Olmos-Mata iD, Ana Muñoz, Juncal Pérez-Somarriba, Noemí Cabello, María José Núñez, Vicente Estrada

Immunity, Inflammation and Disease · 2025-11 · 13 (11)

DOI: 10.1002/iid3.70281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 25.11.2025. Verfasst von Jose-Reynaldo Homen Fernandez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Enfermedades Infecciosas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Mad…. Hauptthemen laut MEDLINE: COVID-19, Respiratory Syncytial Virus Infections, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lower respiratory tract infections (LRTIs) impose a significant global burden, with over 400 million cases annually. This study compares the clinical features of adults hospitalized with respiratory syncytial virus (RSV) and COVID‐19, two viral pathogens with similar presentations but differing epidemiology.

Methods

This cross‐sectional study analyzed 100 adult cases with PCR‐confirmed RSV or COVID‐19, admitted to the hospital from January 2022 to March 2023. Data on clinical, sociodemographic, radiological, treatment, and laboratory variables were extracted from records.

Results

Both cohorts consisted of elderly patients (> 70 years) with multiple comorbidities. Notably, the RSV group had a higher prevalence of CHF (24% vs. 10%, p = 0.014) and COPD (29% vs. 9%, p = 0.001). Radiologically, 51% of RSV patients had normal findings, whereas 48% of COVID‐19 patients exhibited bilateral pneumonia ( p = 0.001). Antimicrobial treatment was administered to 75% of RSV patients compared to 41% of COVID‐19 patients ( p < 0.001). RSV patients had marginally higher leukocyte and neutrophil counts, while COVID‐19 patients showed significantly elevated CRP, ferritin, LDH, ALT, and potassium levels.

Conclusions

Distinct profiles were identified between hospitalized RSV and COVID‐19 patients. RSV patients, mostly older with CHF and COPD, were more likely to receive antibiotics, possibly reflecting the lack of targeted therapies. In contrast, COVID‐19 patients exhibited higher inflammation and lung involvement. These findings highlight the need to refine treatment protocols, enhance antimicrobial stewardship, and develop specific RSV therapies alongside preventive strategies for high‐risk groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Syncytial Virus InfectionsAnti-Infective AgentsHumansMaleFemaleAgedCross-Sectional StudiesSpainMiddle AgedHospitalizationAged, 80 and overAdultSARS-CoV-2Respiratory Syncytial Virus, HumanComorbidity

Stichwörter der Autor:innen

COVID‐19SARS‐CoV2Spainantimicrobial stewardshipcomorbidityepidemiologyhospitalizationinflammatory markersradiographyrespiratory syncytial virus infections

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Servicio de Enfermedades Infecciosas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Centro Sanitario Sandoval, Hospital Clínico San Carlos, Madrid, Spain.

ORCID-Profile: Jose-Reynaldo Homen Fernandez, Adrián Valls Carbó, Carolina Olmos-Mata

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Homen Fernandez, J. R., Armenteros, I., Valls Carbó, A., Barrado, J., Olmos-Mata, C., Muñoz, A., Pérez-Somarriba, J., Cabello, N., Núñez, M. J., & Estrada, V. (2025). Respiratory Syncytial Virus and COVID‐19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use. Immunity, Inflammation and Disease, 13(11). https://doi.org/10.1002/iid3.70281

Vancouver

Homen Fernandez JR, Armenteros I, Valls Carbó A, Barrado J, Olmos-Mata C, Muñoz A, et al. Respiratory Syncytial Virus and COVID‐19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use. Immunity, Inflammation and Disease. 2025;13(11). doi:10.1002/iid3.70281

BibTeX
@article{HomenFernandez2025,
  author = {Homen Fernandez, Jose-Reynaldo and Armenteros, Inés and Valls Carbó, Adrián and Barrado, Julia and Olmos-Mata, Carolina and Muñoz, Ana and Pérez-Somarriba, Juncal and Cabello, Noemí and Núñez, María José and Estrada, Vicente},
  title = {Respiratory Syncytial Virus and COVID‐19 in Hospitalized Adults in Spain: Clinical, Radiological Features and Antimicrobial Use},
  journal = {Immunity, Inflammation and Disease},
  year = {2025},
  volume = {13},
  number = {11},
  doi = {10.1002/iid3.70281}
}
Kostenlos starten →